PartnershipUpdated on 12 March 2026
Bringing Cell Analysis to an Upper Dimension for Bioproduction & CGT
About
HemaVision is industrializing 3D cellular quality control for the life‑science industries. We bring cell analysis to an upper dimension by adding a new analytical layer above current tools: proprietary non‑destructive membrane staining, advanced multi‑plane optical imaging and AI‑based 3D reconstruction turn living cells into quantitative “holograms”, from which we extract phenotypes and QC indicators on their functional state.
This upper‑dimension layer delivers a novel cellular quality‑control module based on 3D membrane morphology and AI that complements existing bioprocess and cell analysis platforms. It fills the gap between environmental/biochemical measurements and the true condition of the producing cells, enabling earlier anomaly detection, fewer batch rejections and better process robustness across bioproduction, R&D and cell & gene therapy workflows.
For Eureka, we seek partners to build a collaborative project around:
– Industrial and clinical use‑cases in bioproduction, precision fermentation, cell & gene therapy and advanced blood/transfusion products, where early detection of 3D cellular drifts in this upper analytical dimension can reduce lot failures and variability.
– Technology integration of HemaVision as a software and/or hardware module into existing imaging platforms and PAT/LIMS/MES environments (e.g. live‑cell imaging, bioreactors, bioanalytics), so that partners can add a “cell functional PAT” block in a higher analytical dimension on top of their current sensors and assays.
– Joint pilots and beta‑sites with imaging platforms and industrial partners to generate large, high‑value 3D datasets, validate SOPs and demonstrate impact on batch robustness, QC precision and sustainability (fewer rejected lots, less waste, better use of infrastructure).
We are particularly interested in equipment manufacturers, CDMOs, biotech/medtech companies and hospital or academic imaging platforms willing to co‑develop applications, integration APIs and future OEM modules around this new upper‑dimension cell quality layer.
Organisation
Similar opportunities
Project cooperation
Bringing Cell Analysis to an Upper Dimension for Bioproduction & CGT
- Early
- Planning
- Research
- Execution
- Technical
- Healthcare
- EU projects
- Biotech, Pharma and Cosmetics
- Partner looking for consortium
- Food, Beverages and Agriculture
- Coordinator looking for partners
Andrei Constantinescu
Founder and CEO - HemaVision at HemaVision
Dijon, France
Expertise
Stem Cells and Regenerative Medicine Platform
- Healthcare
- Biotech, Pharma and Cosmetics
Sonia Thomson
Communication specialist at Biotechnet Switzerland
Muttenz, Switzerland
Expertise
NGS & Microbiome Analytics for Biomarkers, Safety and QC
- Other
- Healthcare
- Environment
- Biotech, Pharma and Cosmetics
- Food, Beverages and Agriculture
Alexandre DOUABLIN
CEO at BIOMNIGENE
Besançon, France